Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
20,707
archived clinical trials in
Gastrointestinal

B0151005 Open-Label Extension Study
A Multicenter Open-label Extension Study For Subjects Who Participated In Study B0151003 (Andante Ii)
Status: Enrolling
Updated:  1/19/2016
Options Health Research
mi
from
Tulsa, OK
B0151005 Open-Label Extension Study
A Multicenter Open-label Extension Study For Subjects Who Participated In Study B0151003 (Andante Ii)
Status: Enrolling
Updated: 1/19/2016
Options Health Research
mi
from
Tulsa, OK
Click here to add this to my saved trials
B0151005 Open-Label Extension Study
A Multicenter Open-label Extension Study For Subjects Who Participated In Study B0151003 (Andante Ii)
Status: Enrolling
Updated:  1/19/2016
Pittsburgh Gastroenterology Associates
mi
from
Pittsburgh, PA
B0151005 Open-Label Extension Study
A Multicenter Open-label Extension Study For Subjects Who Participated In Study B0151003 (Andante Ii)
Status: Enrolling
Updated: 1/19/2016
Pittsburgh Gastroenterology Associates
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
B0151005 Open-Label Extension Study
A Multicenter Open-label Extension Study For Subjects Who Participated In Study B0151003 (Andante Ii)
Status: Enrolling
Updated:  1/19/2016
Research Protocol Management Specialists
mi
from
Pittsburgh, PA
B0151005 Open-Label Extension Study
A Multicenter Open-label Extension Study For Subjects Who Participated In Study B0151003 (Andante Ii)
Status: Enrolling
Updated: 1/19/2016
Research Protocol Management Specialists
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
B0151005 Open-Label Extension Study
A Multicenter Open-label Extension Study For Subjects Who Participated In Study B0151003 (Andante Ii)
Status: Enrolling
Updated:  1/19/2016
Gastro One
mi
from
Germantown, TN
B0151005 Open-Label Extension Study
A Multicenter Open-label Extension Study For Subjects Who Participated In Study B0151003 (Andante Ii)
Status: Enrolling
Updated: 1/19/2016
Gastro One
mi
from
Germantown, TN
Click here to add this to my saved trials
B0151005 Open-Label Extension Study
A Multicenter Open-label Extension Study For Subjects Who Participated In Study B0151003 (Andante Ii)
Status: Enrolling
Updated:  1/19/2016
Vanderbilt University Medical Center-GI Research
mi
from
Nashville, TN
B0151005 Open-Label Extension Study
A Multicenter Open-label Extension Study For Subjects Who Participated In Study B0151003 (Andante Ii)
Status: Enrolling
Updated: 1/19/2016
Vanderbilt University Medical Center-GI Research
mi
from
Nashville, TN
Click here to add this to my saved trials
B0151005 Open-Label Extension Study
A Multicenter Open-label Extension Study For Subjects Who Participated In Study B0151003 (Andante Ii)
Status: Enrolling
Updated:  1/19/2016
Vanderbilt University Medical Center-IDS
mi
from
Nashville, TN
B0151005 Open-Label Extension Study
A Multicenter Open-label Extension Study For Subjects Who Participated In Study B0151003 (Andante Ii)
Status: Enrolling
Updated: 1/19/2016
Vanderbilt University Medical Center-IDS
mi
from
Nashville, TN
Click here to add this to my saved trials
B0151005 Open-Label Extension Study
A Multicenter Open-label Extension Study For Subjects Who Participated In Study B0151003 (Andante Ii)
Status: Enrolling
Updated:  1/19/2016
Austin Gastroenterology, PA
mi
from
Austin, TX
B0151005 Open-Label Extension Study
A Multicenter Open-label Extension Study For Subjects Who Participated In Study B0151003 (Andante Ii)
Status: Enrolling
Updated: 1/19/2016
Austin Gastroenterology, PA
mi
from
Austin, TX
Click here to add this to my saved trials
B0151005 Open-Label Extension Study
A Multicenter Open-label Extension Study For Subjects Who Participated In Study B0151003 (Andante Ii)
Status: Enrolling
Updated:  1/19/2016
Professional Quality Research, Inc.
mi
from
Austin, TX
B0151005 Open-Label Extension Study
A Multicenter Open-label Extension Study For Subjects Who Participated In Study B0151003 (Andante Ii)
Status: Enrolling
Updated: 1/19/2016
Professional Quality Research, Inc.
mi
from
Austin, TX
Click here to add this to my saved trials
B0151005 Open-Label Extension Study
A Multicenter Open-label Extension Study For Subjects Who Participated In Study B0151003 (Andante Ii)
Status: Enrolling
Updated:  1/19/2016
Diagnostic Clinic of Houston
mi
from
Houston, TX
B0151005 Open-Label Extension Study
A Multicenter Open-label Extension Study For Subjects Who Participated In Study B0151003 (Andante Ii)
Status: Enrolling
Updated: 1/19/2016
Diagnostic Clinic of Houston
mi
from
Houston, TX
Click here to add this to my saved trials
B0151005 Open-Label Extension Study
A Multicenter Open-label Extension Study For Subjects Who Participated In Study B0151003 (Andante Ii)
Status: Enrolling
Updated:  1/19/2016
University of Texas Health Science Center at Houston
mi
from
Houston, TX
B0151005 Open-Label Extension Study
A Multicenter Open-label Extension Study For Subjects Who Participated In Study B0151003 (Andante Ii)
Status: Enrolling
Updated: 1/19/2016
University of Texas Health Science Center at Houston
mi
from
Houston, TX
Click here to add this to my saved trials
B0151005 Open-Label Extension Study
A Multicenter Open-label Extension Study For Subjects Who Participated In Study B0151003 (Andante Ii)
Status: Enrolling
Updated:  1/19/2016
Texas Digestive Disease Consultants
mi
from
Southlake, TX
B0151005 Open-Label Extension Study
A Multicenter Open-label Extension Study For Subjects Who Participated In Study B0151003 (Andante Ii)
Status: Enrolling
Updated: 1/19/2016
Texas Digestive Disease Consultants
mi
from
Southlake, TX
Click here to add this to my saved trials
B0151005 Open-Label Extension Study
A Multicenter Open-label Extension Study For Subjects Who Participated In Study B0151003 (Andante Ii)
Status: Enrolling
Updated:  1/19/2016
Clinical Pathologiy Laboratories, Inc, DBA DRL Labs
mi
from
Tyler, TX
B0151005 Open-Label Extension Study
A Multicenter Open-label Extension Study For Subjects Who Participated In Study B0151003 (Andante Ii)
Status: Enrolling
Updated: 1/19/2016
Clinical Pathologiy Laboratories, Inc, DBA DRL Labs
mi
from
Tyler, TX
Click here to add this to my saved trials
B0151005 Open-Label Extension Study
A Multicenter Open-label Extension Study For Subjects Who Participated In Study B0151003 (Andante Ii)
Status: Enrolling
Updated:  1/19/2016
Digestive Health Specialists of Tyler
mi
from
Tyler, TX
B0151005 Open-Label Extension Study
A Multicenter Open-label Extension Study For Subjects Who Participated In Study B0151003 (Andante Ii)
Status: Enrolling
Updated: 1/19/2016
Digestive Health Specialists of Tyler
mi
from
Tyler, TX
Click here to add this to my saved trials
B0151005 Open-Label Extension Study
A Multicenter Open-label Extension Study For Subjects Who Participated In Study B0151003 (Andante Ii)
Status: Enrolling
Updated:  1/19/2016
University Of Utah Hospital
mi
from
Salt Lake City, UT
B0151005 Open-Label Extension Study
A Multicenter Open-label Extension Study For Subjects Who Participated In Study B0151003 (Andante Ii)
Status: Enrolling
Updated: 1/19/2016
University Of Utah Hospital
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
B0151005 Open-Label Extension Study
A Multicenter Open-label Extension Study For Subjects Who Participated In Study B0151003 (Andante Ii)
Status: Enrolling
Updated:  1/19/2016
VC Medical Center Investigative Drug Service (IDS) [Ship Drug To]
mi
from
Richmond, VA
B0151005 Open-Label Extension Study
A Multicenter Open-label Extension Study For Subjects Who Participated In Study B0151003 (Andante Ii)
Status: Enrolling
Updated: 1/19/2016
VC Medical Center Investigative Drug Service (IDS) [Ship Drug To]
mi
from
Richmond, VA
Click here to add this to my saved trials
B0151005 Open-Label Extension Study
A Multicenter Open-label Extension Study For Subjects Who Participated In Study B0151003 (Andante Ii)
Status: Enrolling
Updated:  1/19/2016
U of L Health Care Outpatient Center
mi
from
Louisville, KY
B0151005 Open-Label Extension Study
A Multicenter Open-label Extension Study For Subjects Who Participated In Study B0151003 (Andante Ii)
Status: Enrolling
Updated: 1/19/2016
U of L Health Care Outpatient Center
mi
from
Louisville, KY
Click here to add this to my saved trials
B0151005 Open-Label Extension Study
A Multicenter Open-label Extension Study For Subjects Who Participated In Study B0151003 (Andante Ii)
Status: Enrolling
Updated:  1/19/2016
Metro Health Hospital Endoscopy Unit
mi
from
Wyoming, MI
B0151005 Open-Label Extension Study
A Multicenter Open-label Extension Study For Subjects Who Participated In Study B0151003 (Andante Ii)
Status: Enrolling
Updated: 1/19/2016
Metro Health Hospital Endoscopy Unit
mi
from
Wyoming, MI
Click here to add this to my saved trials
B0151005 Open-Label Extension Study
A Multicenter Open-label Extension Study For Subjects Who Participated In Study B0151003 (Andante Ii)
Status: Enrolling
Updated:  1/19/2016
Huron Gastroenterology Associates
mi
from
Ypsilanti, MI
B0151005 Open-Label Extension Study
A Multicenter Open-label Extension Study For Subjects Who Participated In Study B0151003 (Andante Ii)
Status: Enrolling
Updated: 1/19/2016
Huron Gastroenterology Associates
mi
from
Ypsilanti, MI
Click here to add this to my saved trials
B0151005 Open-Label Extension Study
A Multicenter Open-label Extension Study For Subjects Who Participated In Study B0151003 (Andante Ii)
Status: Enrolling
Updated:  1/19/2016
Present, Chapman, Steinlauf and Marion
mi
from
New York, NY
B0151005 Open-Label Extension Study
A Multicenter Open-label Extension Study For Subjects Who Participated In Study B0151003 (Andante Ii)
Status: Enrolling
Updated: 1/19/2016
Present, Chapman, Steinlauf and Marion
mi
from
New York, NY
Click here to add this to my saved trials
B0151005 Open-Label Extension Study
A Multicenter Open-label Extension Study For Subjects Who Participated In Study B0151003 (Andante Ii)
Status: Enrolling
Updated:  1/19/2016
Mount Sinai School of Medicine
mi
from
New York, NY
B0151005 Open-Label Extension Study
A Multicenter Open-label Extension Study For Subjects Who Participated In Study B0151003 (Andante Ii)
Status: Enrolling
Updated: 1/19/2016
Mount Sinai School of Medicine
mi
from
New York, NY
Click here to add this to my saved trials
B0151005 Open-Label Extension Study
A Multicenter Open-label Extension Study For Subjects Who Participated In Study B0151003 (Andante Ii)
Status: Enrolling
Updated:  1/19/2016
Arthur Asher Kombluth, MD PC
mi
from
New York, NY
B0151005 Open-Label Extension Study
A Multicenter Open-label Extension Study For Subjects Who Participated In Study B0151003 (Andante Ii)
Status: Enrolling
Updated: 1/19/2016
Arthur Asher Kombluth, MD PC
mi
from
New York, NY
Click here to add this to my saved trials
B0151005 Open-Label Extension Study
A Multicenter Open-label Extension Study For Subjects Who Participated In Study B0151003 (Andante Ii)
Status: Enrolling
Updated:  1/19/2016
Vanderbilt University Medical Center-IBD center
mi
from
Nashville, TN
B0151005 Open-Label Extension Study
A Multicenter Open-label Extension Study For Subjects Who Participated In Study B0151003 (Andante Ii)
Status: Enrolling
Updated: 1/19/2016
Vanderbilt University Medical Center-IBD center
mi
from
Nashville, TN
Click here to add this to my saved trials
B0151005 Open-Label Extension Study
A Multicenter Open-label Extension Study For Subjects Who Participated In Study B0151003 (Andante Ii)
Status: Enrolling
Updated:  1/19/2016
Virginia Commonwealth University, Clinical Research Services (CRSU)
mi
from
Richmond, VA
B0151005 Open-Label Extension Study
A Multicenter Open-label Extension Study For Subjects Who Participated In Study B0151003 (Andante Ii)
Status: Enrolling
Updated: 1/19/2016
Virginia Commonwealth University, Clinical Research Services (CRSU)
mi
from
Richmond, VA
Click here to add this to my saved trials
B0151005 Open-Label Extension Study
A Multicenter Open-label Extension Study For Subjects Who Participated In Study B0151003 (Andante Ii)
Status: Enrolling
Updated:  1/19/2016
Concord Repatriation General Hospital
mi
from
Concord,
B0151005 Open-Label Extension Study
A Multicenter Open-label Extension Study For Subjects Who Participated In Study B0151003 (Andante Ii)
Status: Enrolling
Updated: 1/19/2016
Concord Repatriation General Hospital
mi
from
Concord,
Click here to add this to my saved trials
Study to Evaluate the Incidence of Gastric Ulcers Following Administration of Either PA32540 or Enteric Coated Aspirin 325 mg in Subjects Who Are at Risk for Developing Aspirin-Associated Ulcers
A 6-Month, Phase 3, Randomized, Double-Blind, Parallel-Group, Controlled, Multi-Center Study to Evaluate the Incidence of Gastric Ulcers Following Administration of Either PA32540 or Enteric Coated Aspirin 325 mg in Subjects Who Are at Risk for Developing Aspirin-Associated Ulcers
Status: Enrolling
Updated:  1/20/2016
Pozen
mi
from
Chapel Hill, NC
Study to Evaluate the Incidence of Gastric Ulcers Following Administration of Either PA32540 or Enteric Coated Aspirin 325 mg in Subjects Who Are at Risk for Developing Aspirin-Associated Ulcers
A 6-Month, Phase 3, Randomized, Double-Blind, Parallel-Group, Controlled, Multi-Center Study to Evaluate the Incidence of Gastric Ulcers Following Administration of Either PA32540 or Enteric Coated Aspirin 325 mg in Subjects Who Are at Risk for Developing Aspirin-Associated Ulcers
Status: Enrolling
Updated: 1/20/2016
Pozen
mi
from
Chapel Hill, NC
Click here to add this to my saved trials
A Study to Evaluate the Incidence of Gastric Ulcers Following Administration of Either PA32540 or Enteric Coated Aspirin 325 mg in Subjects Who Are at Risk for Developing Aspirin-Associated Ulcers
A 6-Month, Phase 3, Randomized, Double-Blind, Parallel-Group, Controlled, Multi-Center Study to Evaluate the Incidence of Gastric Ulcers Following Administration of Either PA32540 or Enteric Coated Aspirin 325 mg in Subjects Who Are at Risk for Developing Aspirin-Associated Ulcers
Status: Enrolling
Updated:  1/20/2016
Pozen
mi
from
Chapel Hill, NC
A Study to Evaluate the Incidence of Gastric Ulcers Following Administration of Either PA32540 or Enteric Coated Aspirin 325 mg in Subjects Who Are at Risk for Developing Aspirin-Associated Ulcers
A 6-Month, Phase 3, Randomized, Double-Blind, Parallel-Group, Controlled, Multi-Center Study to Evaluate the Incidence of Gastric Ulcers Following Administration of Either PA32540 or Enteric Coated Aspirin 325 mg in Subjects Who Are at Risk for Developing Aspirin-Associated Ulcers
Status: Enrolling
Updated: 1/20/2016
Pozen
mi
from
Chapel Hill, NC
Click here to add this to my saved trials
Prospective Validation of a Plasma Transfusion Dosing Algorithm in Patients With Chronic Liver Disease
Prospective Validation of a Plasma Transfusion Dosing Algorithm in Patients With Chronic Liver Disease
Status: Enrolling
Updated:  1/20/2016
University of Colorado Hospital
mi
from
Aurora, CO
Prospective Validation of a Plasma Transfusion Dosing Algorithm in Patients With Chronic Liver Disease
Prospective Validation of a Plasma Transfusion Dosing Algorithm in Patients With Chronic Liver Disease
Status: Enrolling
Updated: 1/20/2016
University of Colorado Hospital
mi
from
Aurora, CO
Click here to add this to my saved trials
Cathartic-Free DECT Colonography for Detection of Colonic Polyps
Cathartic-Free Dual Energy Computerized Tomography (DECT) Colonography.
Status: Enrolling
Updated:  1/20/2016
Mayo Clinic
mi
from
Scottsdale, AZ
Cathartic-Free DECT Colonography for Detection of Colonic Polyps
Cathartic-Free Dual Energy Computerized Tomography (DECT) Colonography.
Status: Enrolling
Updated: 1/20/2016
Mayo Clinic
mi
from
Scottsdale, AZ
Click here to add this to my saved trials
Cathartic-Free DECT Colonography for Detection of Colonic Polyps
Cathartic-Free Dual Energy Computerized Tomography (DECT) Colonography.
Status: Enrolling
Updated:  1/20/2016
The Mayo Clinic
mi
from
Rochester, MN
Cathartic-Free DECT Colonography for Detection of Colonic Polyps
Cathartic-Free Dual Energy Computerized Tomography (DECT) Colonography.
Status: Enrolling
Updated: 1/20/2016
The Mayo Clinic
mi
from
Rochester, MN
Click here to add this to my saved trials
Evaluation of a New Oral Contrast Agent for MR Enterography in the Assessment of Crohn Disease in the Small Bowel
Evaluation of a New Oral Contrast Agent for MR Enterography in the Assessment of Crohn Disease in the Small Bowel
Status: Enrolling
Updated:  1/20/2016
The Mayo Clinic
mi
from
Rochester, MN
Evaluation of a New Oral Contrast Agent for MR Enterography in the Assessment of Crohn Disease in the Small Bowel
Evaluation of a New Oral Contrast Agent for MR Enterography in the Assessment of Crohn Disease in the Small Bowel
Status: Enrolling
Updated: 1/20/2016
The Mayo Clinic
mi
from
Rochester, MN
Click here to add this to my saved trials
Study to Evaluate the Long-Term Safety of PA32540 in Subjects Who Are at Risk for Developing Aspirin-Associated Gastric Ulcers
A 12-Month, Phase 3, Open-Label, Multi-Center Study to Evaluate the Long-Term Safety of PA32540 in Subjects Who Are at Risk for Developing Aspirin-Associated Gastric Ulcers
Status: Enrolling
Updated:  1/20/2016
Pozen
mi
from
Chapel Hill, NC
Study to Evaluate the Long-Term Safety of PA32540 in Subjects Who Are at Risk for Developing Aspirin-Associated Gastric Ulcers
A 12-Month, Phase 3, Open-Label, Multi-Center Study to Evaluate the Long-Term Safety of PA32540 in Subjects Who Are at Risk for Developing Aspirin-Associated Gastric Ulcers
Status: Enrolling
Updated: 1/20/2016
Pozen
mi
from
Chapel Hill, NC
Click here to add this to my saved trials
Prospective Evaluation of Idiopathic Pancreatitis: Role of Endoscopic Ultrasonography
Prospective Evaluation of Idiopathic Pancreatitis: Role of Endoscopic Ultrasonography
Status: Enrolling
Updated:  1/21/2016
University of Alabama
mi
from
Birmingham, AL
Prospective Evaluation of Idiopathic Pancreatitis: Role of Endoscopic Ultrasonography
Prospective Evaluation of Idiopathic Pancreatitis: Role of Endoscopic Ultrasonography
Status: Enrolling
Updated: 1/21/2016
University of Alabama
mi
from
Birmingham, AL
Click here to add this to my saved trials
Evaluation of Liver Disease With Elastography Measurements in Patients Undergoing Liver Transplant Surgery
Quantitative Evaluation of Liver Disease With Liver Elastography Measurements Using the Supersonic Imagine Aixplorer ShearWaveTM Elastography Ultrasound Machine in Patients Undergoing Liver Transplant Surgery
Status: Enrolling
Updated:  1/21/2016
Baylor University Medical Center
mi
from
Dallas, TX
Evaluation of Liver Disease With Elastography Measurements in Patients Undergoing Liver Transplant Surgery
Quantitative Evaluation of Liver Disease With Liver Elastography Measurements Using the Supersonic Imagine Aixplorer ShearWaveTM Elastography Ultrasound Machine in Patients Undergoing Liver Transplant Surgery
Status: Enrolling
Updated: 1/21/2016
Baylor University Medical Center
mi
from
Dallas, TX
Click here to add this to my saved trials
Trial on Wheeled Mobility for Preventing Pressure Ulcers
RCT on Wheeled Mobility for Preventing Pressure Ulcers
Status: Enrolling
Updated:  1/25/2016
University of Pittsburgh
mi
from
Pittsburgh, PA
Trial on Wheeled Mobility for Preventing Pressure Ulcers
RCT on Wheeled Mobility for Preventing Pressure Ulcers
Status: Enrolling
Updated: 1/25/2016
University of Pittsburgh
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
Intra-patient Dose Escalation Study Evaluating Efficacy, Safety and Pharmacokinetics of Pasireotide (SOM230) Subcutaneous (s.c.) Followed by Pasireotide LAR in Patients With Dumping Syndrome
A Multi-center, Intra-patient Dose Escalation Phase II Study to Evaluate the Preliminary Efficacy, Safety and Pharmacokinetics of Pasireotide (SOM230) Subcutaneous (s.c.) Followed by Pasireotide LAR in Patients With Dumping Syndrome
Status: Enrolling
Updated:  1/25/2016
Ximed Center for Weight Management Ximed Research
mi
from
La Jolla, CA
Intra-patient Dose Escalation Study Evaluating Efficacy, Safety and Pharmacokinetics of Pasireotide (SOM230) Subcutaneous (s.c.) Followed by Pasireotide LAR in Patients With Dumping Syndrome
A Multi-center, Intra-patient Dose Escalation Phase II Study to Evaluate the Preliminary Efficacy, Safety and Pharmacokinetics of Pasireotide (SOM230) Subcutaneous (s.c.) Followed by Pasireotide LAR in Patients With Dumping Syndrome
Status: Enrolling
Updated: 1/25/2016
Ximed Center for Weight Management Ximed Research
mi
from
La Jolla, CA
Click here to add this to my saved trials
Intra-patient Dose Escalation Study Evaluating Efficacy, Safety and Pharmacokinetics of Pasireotide (SOM230) Subcutaneous (s.c.) Followed by Pasireotide LAR in Patients With Dumping Syndrome
A Multi-center, Intra-patient Dose Escalation Phase II Study to Evaluate the Preliminary Efficacy, Safety and Pharmacokinetics of Pasireotide (SOM230) Subcutaneous (s.c.) Followed by Pasireotide LAR in Patients With Dumping Syndrome
Status: Enrolling
Updated:  1/25/2016
Stanford University Medical Center SC - SOM230X2203
mi
from
Stanford, CA
Intra-patient Dose Escalation Study Evaluating Efficacy, Safety and Pharmacokinetics of Pasireotide (SOM230) Subcutaneous (s.c.) Followed by Pasireotide LAR in Patients With Dumping Syndrome
A Multi-center, Intra-patient Dose Escalation Phase II Study to Evaluate the Preliminary Efficacy, Safety and Pharmacokinetics of Pasireotide (SOM230) Subcutaneous (s.c.) Followed by Pasireotide LAR in Patients With Dumping Syndrome
Status: Enrolling
Updated: 1/25/2016
Stanford University Medical Center SC - SOM230X2203
mi
from
Stanford, CA
Click here to add this to my saved trials
Intra-patient Dose Escalation Study Evaluating Efficacy, Safety and Pharmacokinetics of Pasireotide (SOM230) Subcutaneous (s.c.) Followed by Pasireotide LAR in Patients With Dumping Syndrome
A Multi-center, Intra-patient Dose Escalation Phase II Study to Evaluate the Preliminary Efficacy, Safety and Pharmacokinetics of Pasireotide (SOM230) Subcutaneous (s.c.) Followed by Pasireotide LAR in Patients With Dumping Syndrome
Status: Enrolling
Updated:  1/25/2016
Mayo Clinic - Rochester Mayo MN
mi
from
Rochester, MN
Intra-patient Dose Escalation Study Evaluating Efficacy, Safety and Pharmacokinetics of Pasireotide (SOM230) Subcutaneous (s.c.) Followed by Pasireotide LAR in Patients With Dumping Syndrome
A Multi-center, Intra-patient Dose Escalation Phase II Study to Evaluate the Preliminary Efficacy, Safety and Pharmacokinetics of Pasireotide (SOM230) Subcutaneous (s.c.) Followed by Pasireotide LAR in Patients With Dumping Syndrome
Status: Enrolling
Updated: 1/25/2016
Mayo Clinic - Rochester Mayo MN
mi
from
Rochester, MN
Click here to add this to my saved trials
Intra-patient Dose Escalation Study Evaluating Efficacy, Safety and Pharmacokinetics of Pasireotide (SOM230) Subcutaneous (s.c.) Followed by Pasireotide LAR in Patients With Dumping Syndrome
A Multi-center, Intra-patient Dose Escalation Phase II Study to Evaluate the Preliminary Efficacy, Safety and Pharmacokinetics of Pasireotide (SOM230) Subcutaneous (s.c.) Followed by Pasireotide LAR in Patients With Dumping Syndrome
Status: Enrolling
Updated:  1/25/2016
Montefiore Medical Center SC - 3
mi
from
Bronx, NY
Intra-patient Dose Escalation Study Evaluating Efficacy, Safety and Pharmacokinetics of Pasireotide (SOM230) Subcutaneous (s.c.) Followed by Pasireotide LAR in Patients With Dumping Syndrome
A Multi-center, Intra-patient Dose Escalation Phase II Study to Evaluate the Preliminary Efficacy, Safety and Pharmacokinetics of Pasireotide (SOM230) Subcutaneous (s.c.) Followed by Pasireotide LAR in Patients With Dumping Syndrome
Status: Enrolling
Updated: 1/25/2016
Montefiore Medical Center SC - 3
mi
from
Bronx, NY
Click here to add this to my saved trials
Intra-patient Dose Escalation Study Evaluating Efficacy, Safety and Pharmacokinetics of Pasireotide (SOM230) Subcutaneous (s.c.) Followed by Pasireotide LAR in Patients With Dumping Syndrome
A Multi-center, Intra-patient Dose Escalation Phase II Study to Evaluate the Preliminary Efficacy, Safety and Pharmacokinetics of Pasireotide (SOM230) Subcutaneous (s.c.) Followed by Pasireotide LAR in Patients With Dumping Syndrome
Status: Enrolling
Updated:  1/25/2016
Texas tech university health science center
mi
from
El Paso, TX
Intra-patient Dose Escalation Study Evaluating Efficacy, Safety and Pharmacokinetics of Pasireotide (SOM230) Subcutaneous (s.c.) Followed by Pasireotide LAR in Patients With Dumping Syndrome
A Multi-center, Intra-patient Dose Escalation Phase II Study to Evaluate the Preliminary Efficacy, Safety and Pharmacokinetics of Pasireotide (SOM230) Subcutaneous (s.c.) Followed by Pasireotide LAR in Patients With Dumping Syndrome
Status: Enrolling
Updated: 1/25/2016
Texas tech university health science center
mi
from
El Paso, TX
Click here to add this to my saved trials
Intra-patient Dose Escalation Study Evaluating Efficacy, Safety and Pharmacokinetics of Pasireotide (SOM230) Subcutaneous (s.c.) Followed by Pasireotide LAR in Patients With Dumping Syndrome
A Multi-center, Intra-patient Dose Escalation Phase II Study to Evaluate the Preliminary Efficacy, Safety and Pharmacokinetics of Pasireotide (SOM230) Subcutaneous (s.c.) Followed by Pasireotide LAR in Patients With Dumping Syndrome
Status: Enrolling
Updated:  1/25/2016
Virginia Endocrinology Research SC
mi
from
Chesapeake, VA
Intra-patient Dose Escalation Study Evaluating Efficacy, Safety and Pharmacokinetics of Pasireotide (SOM230) Subcutaneous (s.c.) Followed by Pasireotide LAR in Patients With Dumping Syndrome
A Multi-center, Intra-patient Dose Escalation Phase II Study to Evaluate the Preliminary Efficacy, Safety and Pharmacokinetics of Pasireotide (SOM230) Subcutaneous (s.c.) Followed by Pasireotide LAR in Patients With Dumping Syndrome
Status: Enrolling
Updated: 1/25/2016
Virginia Endocrinology Research SC
mi
from
Chesapeake, VA
Click here to add this to my saved trials
Intra-patient Dose Escalation Study Evaluating Efficacy, Safety and Pharmacokinetics of Pasireotide (SOM230) Subcutaneous (s.c.) Followed by Pasireotide LAR in Patients With Dumping Syndrome
A Multi-center, Intra-patient Dose Escalation Phase II Study to Evaluate the Preliminary Efficacy, Safety and Pharmacokinetics of Pasireotide (SOM230) Subcutaneous (s.c.) Followed by Pasireotide LAR in Patients With Dumping Syndrome
Status: Enrolling
Updated:  1/25/2016
Novartis Investigative Site
mi
from
Brugge,
Intra-patient Dose Escalation Study Evaluating Efficacy, Safety and Pharmacokinetics of Pasireotide (SOM230) Subcutaneous (s.c.) Followed by Pasireotide LAR in Patients With Dumping Syndrome
A Multi-center, Intra-patient Dose Escalation Phase II Study to Evaluate the Preliminary Efficacy, Safety and Pharmacokinetics of Pasireotide (SOM230) Subcutaneous (s.c.) Followed by Pasireotide LAR in Patients With Dumping Syndrome
Status: Enrolling
Updated: 1/25/2016
Novartis Investigative Site
mi
from
Brugge,
Click here to add this to my saved trials
MD2Me - Texting to Promote Chronic Disease Management
TAHLC - Texting to Promote Adolescent Health Liaisons and Chronic Disease Management
Status: Enrolling
Updated:  1/25/2016
The University of California, San Diego
mi
from
La Jolla, CA
MD2Me - Texting to Promote Chronic Disease Management
TAHLC - Texting to Promote Adolescent Health Liaisons and Chronic Disease Management
Status: Enrolling
Updated: 1/25/2016
The University of California, San Diego
mi
from
La Jolla, CA
Click here to add this to my saved trials
Short Bowel Syndrome and Teduglutide Versus Placebo
Acute Effects of a Glucagon-like Peptide 2 Analog, Teduglutide, on Gastrointestinal Motor Function and Permeability in Patients With Short Bowel Syndrome on Home Parenteral Nutrition
Status: Enrolling
Updated:  1/25/2016
Mayo Clinic Rochester
mi
from
Rochester, MN
Short Bowel Syndrome and Teduglutide Versus Placebo
Acute Effects of a Glucagon-like Peptide 2 Analog, Teduglutide, on Gastrointestinal Motor Function and Permeability in Patients With Short Bowel Syndrome on Home Parenteral Nutrition
Status: Enrolling
Updated: 1/25/2016
Mayo Clinic Rochester
mi
from
Rochester, MN
Click here to add this to my saved trials
Evaluation of Urinary Isoprostanes in the Assessment of Children With Inflammatory Bowel Disease
Phase I Evaluation of Urinary Isoprostane Levels in Pediatric Patients With Inflammatory and Non-Inflammatory Gastrointestinal Disease
Status: Enrolling
Updated:  1/26/2016
Children's Hospital
mi
from
Boston, MA
Evaluation of Urinary Isoprostanes in the Assessment of Children With Inflammatory Bowel Disease
Phase I Evaluation of Urinary Isoprostane Levels in Pediatric Patients With Inflammatory and Non-Inflammatory Gastrointestinal Disease
Status: Enrolling
Updated: 1/26/2016
Children's Hospital
mi
from
Boston, MA
Click here to add this to my saved trials
Study to Identify Non-Invasive Markers of Gastrointestinal Allergy
Non Invasive Markers in the Diagnosis and Interval Assessment of Children and Adults With Known or Suspected Allergic Disease
Status: Enrolling
Updated:  1/26/2016
Children's Hospital
mi
from
Boston, MA
Study to Identify Non-Invasive Markers of Gastrointestinal Allergy
Non Invasive Markers in the Diagnosis and Interval Assessment of Children and Adults With Known or Suspected Allergic Disease
Status: Enrolling
Updated: 1/26/2016
Children's Hospital
mi
from
Boston, MA
Click here to add this to my saved trials
Study of Nutrition in Acute Pancreatitis
Feeding and Pancreatic Rest in Acute Pancreatitis
Status: Enrolling
Updated:  1/26/2016
Indiana University
mi
from
Indianapolis, IN
Study of Nutrition in Acute Pancreatitis
Feeding and Pancreatic Rest in Acute Pancreatitis
Status: Enrolling
Updated: 1/26/2016
Indiana University
mi
from
Indianapolis, IN
Click here to add this to my saved trials
Study of Nutrition in Acute Pancreatitis
Feeding and Pancreatic Rest in Acute Pancreatitis
Status: Enrolling
Updated:  1/26/2016
University of Pittsburgh Medical Center
mi
from
Pittsburgh, PA
Study of Nutrition in Acute Pancreatitis
Feeding and Pancreatic Rest in Acute Pancreatitis
Status: Enrolling
Updated: 1/26/2016
University of Pittsburgh Medical Center
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
Study of Nutrition in Acute Pancreatitis
Feeding and Pancreatic Rest in Acute Pancreatitis
Status: Enrolling
Updated:  1/26/2016
University of Alabama
mi
from
Birmingham, AL
Study of Nutrition in Acute Pancreatitis
Feeding and Pancreatic Rest in Acute Pancreatitis
Status: Enrolling
Updated: 1/26/2016
University of Alabama
mi
from
Birmingham, AL
Click here to add this to my saved trials
Study of Nutrition in Acute Pancreatitis
Feeding and Pancreatic Rest in Acute Pancreatitis
Status: Enrolling
Updated:  1/26/2016
University of Florida College of Medicine
mi
from
Gainesville, FL
Study of Nutrition in Acute Pancreatitis
Feeding and Pancreatic Rest in Acute Pancreatitis
Status: Enrolling
Updated: 1/26/2016
University of Florida College of Medicine
mi
from
Gainesville, FL
Click here to add this to my saved trials
Nutrition and Body Composition in Acute Lymphoblastic Leukemia
Nutrition and Body Composition in Acute Lymphoblastic Leukemia (Environment and Microenvironment in ALL #2)
Status: Enrolling
Updated:  1/26/2016
Childrens Hospital Los Angeles
mi
from
Los Angeles, CA
Nutrition and Body Composition in Acute Lymphoblastic Leukemia
Nutrition and Body Composition in Acute Lymphoblastic Leukemia (Environment and Microenvironment in ALL #2)
Status: Enrolling
Updated: 1/26/2016
Childrens Hospital Los Angeles
mi
from
Los Angeles, CA
Click here to add this to my saved trials